CAGR of 2.85%, Antihypertensive Drugs Market to hit USD 29.35 Billion in 2028, Says Brandessence Market Research – Yahoo Finance

LONDON, April 11, 2022 /PRNewswire/ — The Antihypertensive Drugs Market Growth is expected to record a valuation of USD 29.35 Billion by 2028, Registering to Accelerate at a 2.85% CAGR, Global Antihypertensive Drugs Market size was Valued at USD 24.11 Billion in 2021. According to the most recent study by Brandessence Market Research & Consulting Pvt ltd.
The global antihypertensive drugs market is one which is really competitive and the major players are adopting many different strategies for getting the biggest share in the market. These strategies like partnership, product launch and collaboration are helping them increase their market share.
Antihypertensive drugs Key Players focusing on the Market Report: Novartis, Merck, Astra Zeneca, Daiichi Sankyo, CJ Healthcare, Bayer, Boryung Pharmaceutical, Takeda, Actelion, United Therapeutics, Pfizer, Johnson & Johnson, Sanofi, Lupin, Ranbaxy Laboratories, JW Pharmaceutical, Gilead, Cipla and others.
Get Sample of Report at https://brandessenceresearch.com/requestSample/PostId/516
Antihypertensive Drugs Market: Market Scope:
The antihypertensive drugs market all over the world has shown signs of growth in the recent past and the growth is expected to increase in the coming years as well. Hypertension refers to a medical condition which has long-term effects and is market by higher blood pressure in arteries that sees persistent elevation. The antihypertensives are being used for the treatment of patients who suffer from hypertension or high blood-pressure. It is a significant disorder and is often accompanied with many serious complications like heart failure, heart attack and other disorders like dementia. Hypertension is an illness which requires diagnosis early and it needs to be treated early too. Some drugs which are used for the hypertension treatment include ACE inhibitors, diuretics and vasodilators.
Antihypertensive Drugs Market: Market segmentation
Antihypertensive drugs classification has been done based on distribution channel, therapeutic class and region. In terms of the therapeutic class, this is a market which has been classified into the ACE Inhibitors, diuretics, vasodilators, calcium channel blockers and others. In terms of the distribution channel, it has been segmented into hospital pharmacy, retail pharmacy, e-commerce and others. In terms of region, the market has been segmented into North America, Asia Pacific, Europe and LAMEA.
On the basis of therapeutic class, the calcium channel blockers are the ones which occupy the biggest share in the market. This is because they have exhibited the lowest side-effects among the other drugs which are in the antihypertensive market. The segment which is going to see the biggest growth here is the ACE Inhibitors segment in the coming years because of the overall positive impact it has and the decreasing progression of kidney diseases.
In terms of distribution channel, the segment of hospitals has been occupying the biggest share. This is because of the rise in hospitals all over the worldwide. Moreover, the drugs are often given on prescription and that prescription usually is given by the healthcare professionals who are specialized and available in the hospitals. This is a big reason for the growth in the market demand for this segment. The highest growth is in the e-commerce segment as the surge of internet takes place in the world.
Get Methodology at https://brandessenceresearch.com/requestMethodology/PostId/516
Antihypertensive Drugs Market: Market Drivers
The major factor which contributes towards the antihypertensive drugs market growing so rapidly is the significant increase in the number of hypertension cases all over the world. In addition, there is a significant attempt to raise awareness about the complications which are associated with hypertension and that is a significant factor which is fueling the growth of the global market. Furthermore, the increasing geriatric population and the lifestyles becoming sedentary are factors which are increasing the growth of the global market significantly. Factors which might hinder the growth of the global antihypertensive medicine market are factors such as patent expirations which have happened off late.
Among the factors which are foremost in increasing the growth of the global antihypertensive drugs market is the rampant rise in the incidences of hypertension. Studies have shown that hypertension has become an illness which if left untreated at early stages can go on and become a fatal illness which could affect the heart of the patient. There are attempts being made to increase mass awareness about the effects of hypertension. The world in the recent past has become more digital and that has led to a scenario where the lifestyles are becoming increasingly sedentary. The constant work pressure and unhealthy eating habits have increasingly led to a rise in the number of cases of hypertension. This has also meant that there is a need for early diagnosis and treatment of hypertension is important for the patients. All these factors have increasingly bolstered the demand for the hypertension drugs. The antihypertensive drugs are usually avoided during pregnancy in order to avoid any kind of complications.
Combination therapies are recently witnessing major applications in comparison to the monotherapy treatment form. Monotherapy refers to using one drug while the combination therapy is one where the hypertensive mechanisms are acted upon in multiple ways. The latter usually involves two drugs which give varying action mechanisms that can lead to better effects than monotherapy. Combination therapy helps in reducing the cerebrovascular events by half and coronary issues by a significant margin too. Thereby, the combination therapy is a better way to protect the organ by giving a lower dose in comparison to the monotherapy and it also has a wider acceptance all over the world which is proving as a lucrative opportunity for the companies which want to invest in this market.
The antihypertensive drugs size however is restrained in the developing countries as the awareness remains lower. Many people in the developing countries are known to neglect their health checkups and have really low knowledge levels about the hypertension and its conditions. This makes it difficult for all the players to have any profit in the developing regions.
Regional Analysis:
In terms of region, the North American region has been gaining the biggest share in the market and is going to see further growth. This is going to continue as a trend in the coming years as the availability of the drugs becomes easier. Furthermore, there is a surge in the incidences of hypertension and related illnesses in the region and higher population coming in the geriatric bracket is going to be one of the factors which leads to it being a prominent market. The highest growth is going to take place in the Asia Pacific region which is due to the growing literacy rates and efforts being done to improve awareness of the disease.
On Special Requirement Antihypertensive Drugs Market Report is also available for below region:
North America
U.S, Canada
Europe
Germany, France,U.K., Italy, Spain, Sweden, Netherland, Turkey, Switzerland, Belgium, Rest of Europe
Asia-Pacific
South_Korea, Japan, China, India, Australia, Philippines, Singapore, Malaysia, Thailand, Indonesia, Rest of APAC
Latin America
Mexico, Colombia, Brazil, Argentina, Peru, Rest of Latin America
Middle East and Africa
Saudi Arabia, UAE, Egypt, South Africa, Rest Of MEA
Get Full Access of all Report: https://brandessenceresearch.com/healthcare/antihypertensive-drugs-market-size
Related Reports:
Color Cosmetics Market size to hit USD 112.90 Billion in 2028
Metaverse Real Estate Market is Growing at 31.2% CAGR to 2028
Metaverse Market Size is Expected to Touch 716.5 Billion by 2027
Silicon Photonics Market Size is Expected to Reach USD 7253.6 Million in 2028
Automotive Diagnostic Scan Tools Market Size to hit USD 46.17 Billion in 2028
CRM Software Market to hit USD 100.63 Billion in 2028
Frozen Potato Market Size to hit USD 81.69 Billion in 2028
Cleaning Robot Market Size to hit USD 34.94 Billion in 2028
Medical Polymers Market to hit USD 34.68 Billion in 2028
i-Factor: Live Market intelligence platform
i-Factor is our guaranteed seal to keep our clients ahead of the competition, always. This knowledge platform delivers real-time updates on key economic indicators, competitive landscape, chang ing demand, trends, customized regional insights, and more. The platform visualizes key data points to help make decision making agile, trustworthy, and holistic. Register for free trail here at https://brandessenceresearch.com/i-factor/login/userRegister
Brandessence Market Research & Consulting Pvt ltd.
Brandessence market research publishes market research reports & business insights produced by highly qualified and experienced industry analysts. Our research reports are available in a wide range of industry verticals including aviation, food & beverage, healthcare, ICT, Construction, Chemicals and lot more. Brand Essence Market Research report will be best fit for senior executives, business development managers, marketing managers, consultants, CEOs, CIOs, COOs, and Directors, governments, agencies, organizations and Ph.D. Students. We have a delivery center in Pune, India and our sales office is in London.
Website: https://brandessenceresearch.com
Blog: Targeting Pods Companies
Follow Us: Linkedin
Mr. Vishal Sawant
Email: vishal@brandessenceresearch.com
Email: Sales@brandessenceresearch.com
Corporate Sales: +44-2038074155
Asia Office: +917447409162
View original content:https://www.prnewswire.com/news-releases/cagr-of-2-85-antihypertensive-drugs-market-to-hit-usd-29-35-billion-in-2028–says-brandessence-market-research-301522659.html
SOURCE Brandessence Market Research And Consulting Private Limited
Warren Buffett needed just two weeks to put together Berkshire Hathaway Inc's $11.6 billion takeover of Alleghany Corp, its largest acquisition in six years, even as he balked at paying the insurer's banking fee, a regulatory filing on Monday shows. Alleghany said its Chief Executive Officer Joseph Brandon met with Buffett for dinner in New York City on March 7, where after some "casual conversation" Buffett offered $850 per share in cash for the company, less the fee for bankers at Goldman Sachs.
The bad streak continues for Nvidia . The semiconductor manufacturer starts the second quarter as it ended the first: badly. During the week of April 4 to April 8, the company known for its graphics chips for gaming and artificial intelligence saw its market capitalization falling from $665.1 billion on April 1 to $576.1 billion on April 8.
‘No one would have flinched if our meal was just $3 more, but the way it was broken out was just weird and struck us the wrong way.’
AT&T has officially spun off its media business, with Warner Bros. Discovery trading on its own for the first time on Monday. AT&T (ticker: T) cut its dividend as part of the spinoff—a point of contention for many AT&T shareholders—but the payout remains generous at an annual $1.11 per share. AT&T completed its spinoff of WarnerMedia on Friday, and the stocks began trading separately on Monday.
Dow Jones futures were lower late. Here's what to do after today's stock market sell-off ahead of Tuesday's key inflation report.
Starbucks has experienced phenomenal growth and success. Learn more about Starbucks competitors and where the company stands in relation to them.
Yahoo Finance's Ines Ferré breaks down trending tickers in the stock market today.
Down doesn’t mean out. When a stock takes a tumble, investors sometimes jump the gun and assume that the name has reached the end of the line. Sure, a significant share price decline should sound the alarm bells, as it could indicate underlying problems with the business or insurmountable headwinds. However, there’s another side to the story. These falls could reflect temporary challenges that can ultimately be overcome, with the lower prices presenting an opportunity to get in on the action bef
A look at some of the stocks that have seen recent share price weakness which may be worth consideration.
Yahoo Finance Live’s Emily McCormick and Brian Sozzi report that the WarnerMedia-Discover merger is now complete.
A downgrade from R.W. Baird appears to be to blame for Nvidia stock suffering today — but Baird isn't entirely to blame. Part of this is Nvidia's own fault. This morning, an analyst at Baird pulled his buy rating from Nvidia and downgraded the shares to neutral — with a $225 price target that was below Nvidia's closing price from Friday.
Yahoo Finance's Pras Subramanian explains how Chinese COVID lockdowns are impacting EV production and sales, in addition to talking about the New York Auto Show's return.
(Bloomberg) — Russia’s crude oil exports, a key source of revenue for Vladimir Putin’s regime, are showing no signs that they are starting to crumble amid the disappearance of European buyers.Most Read from BloombergUkraine Update: Austria Chancellor to Meet Putin; New War FrontCovid Could Be Surging in the U.S. Right Now and We Might Not Even Know ItMusk Rejects Twitter’s Offer to Join Board in Surprise TwistSingapore’s Lee Warns U.S. Against Isolating China Over UkraineRussian Railways Ruled
The one good thing about a market downturn? You get lots of opportunities to load up on shares at a discount entry point. And who doesn’t like a discount? With the way the markets have performed so far this year, there are stocks in every segment which could potentially offer plenty of rewards. CNBC’s Jim Cramer thinks there are several names in the retail sector which look particularly enticing right now, ones for which the term “beaten-down” readily applies. Some rallied nicely toward the end
(Bloomberg) — The feel-good days for global markets at the end of March are firmly over.Most Read from BloombergUkraine Update: U.S. Warns India Over Russian Energy ImportsUkraine Update: Austria Chancellor to Meet Putin; New War FrontEurope Moves to Arm Ukraine as Sanctions Fail to Sway PutinCovid Could Be Surging in the U.S. Right Now and We Might Not Even Know ItUkraine Seeks Russia Assets, Oil Fleet Seizure as ReparationsEverything from stocks to bonds is falling — even oil has pulled back
Google's Sundar Pichai and Microsoft's Satya Nadella are joined buy more Indian origin leaders like Raj Subramaniam, Leena Nair, and Arvind Krishna at the top.
(Bloomberg) — Daily Journal Corp., a newspaper and software business that counts Charlie Munger as one of the overseers of its stock portfolio, cut its stake in Chinese internet giant Alibaba Group Holding Ltd. by roughly half. Most Read from BloombergUkraine Update: U.S. Warns India Over Russian Energy ImportsUkraine Update: Austria Chancellor to Meet Putin; New War FrontEurope Moves to Arm Ukraine as Sanctions Fail to Sway PutinCovid Could Be Surging in the U.S. Right Now and We Might Not Eve
Shares of Advanced Micro Devices (NASDAQ: AMD) were falling today, as much as 5%, before settling into a 4.6% loss as of 12:30 p.m. ET. One can chalk up today's decline to two things: First, the 10-Year Treasury bond continued its ascent, reaching 2.77% today — that's up more than an entire percentage point since the beginning of the year. Rapidly rising long-term rates tend to hurt high-multiple growth stocks, and at 38 times earnings, AMD is certainly that.
The spinoff has the assets to be a winner in the streaming wars and a cheap stock to get investors interested.
Shares of Nvidia Corp. shares were slipping Monday after an analyst took a more cautious outlook on the company's gaming business.

source

Share:

Pulse Handshak

Pulse Handshak

Collaborative online survey tool for the market research industry. Remote assisted surveying just like face-to-face interviews. Here interviewers can talk to the respondent over the web-console without the need for any other communication channel and share the same Q're with responses and click actions.

Pulse FE

Pulse FE

Pulse Field Expert or Pulse FE is the main platform for both offline and online survey at softofficepro.com. It is robust and used by hundreds of clients over tens of years with millions of responses. Do it once Q're and deploy on both offline devices (android) and online forms makes it a great cost effective platform for any kind of responses

Pulse Ultimate

Pulse Ultimate

Pulse Ultimate is targeted for tracking studies and retail audits. An offline survey system offering extreme field control including processes like data quality check, back-check, rework, comparison with previous wave data etc. helps to get the best results on a day-to-day basis

More Posts